Breast carcinoma tumour-infiltrating lymphocytes in pre- and post-systemic therapy in HIV-positive and HIV-negative women
This study found no significant differences in TILs between HIV-positive and HIV-negative women with breast cancer. There is a need for further research on the prognostic value of TILs, especially for guiding additional treatment options including the use of immune checkpoint inhibitors.
Authors
- Jenny Edge (ORCID: https://orcid.org/0000-0003-3005-7254)
- Louis de Jager (ORCID: https://orcid.org/0000-0003-4401-6672)
- M. Adam (ORCID: https://orcid.org/0000-0002-4826-3681)
Institutions
- University of the Witwatersrand (ZA)
- Stellenbosch University (ZA)
Publication Details
- Journal
- Southern African Journal of HIV Medicine
- Published
- 2025-10-16
- DOI
- https://doi.org/10.4102/sajhivmed.v26i1.1741
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00